Gynecare Thermachoice III Uterine Balloon Therapy System Ethicon recalled over fire hazard
- Recall date
- December 3, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Ethicon, Inc. recalls Gynecare Thermachoice III Uterine Balloon Therapy System Ethicon, Inc. The GYNECARE THERMACHOICE¿ III Uterine Balloon T…
- Recall number
- Z-0602-2016
- FDA classification
- Class II
- Brand / firm
- Ethicon, Inc.
- Sold / distributed
- Worldwide Distribution: US (nationwide) including Puerto Rico and countries of: India, Belgium, Argentina, Mexico, Brazil, Canada, Colombia, Ecuador, Singapore, Aruba and Venezuela.
Why it was recalled
Stability data does not substantiate the labeled two-year shelf life of affected product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Gynecare Thermachoice III Uterine Balloon Therapy System Ethicon, Inc. The GYNECARE THERMACHOICE¿ III Uterine Balloon Therapy (UBT) System is a thermal balloon ablation device intended to ablate the endometrial lining of the uterus in pre-menopausal women with menorrhagia (excessive uterine bleeding) due to benign causes for whom childbearing is complete.
Get recall alerts
Free email alert whenever Ethicon, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Ethicon, Inc.